Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $1079.28
SARASOTA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced...
Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care...
Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced...
HIGHLIGHTS Annual revenues of A$25.0 million, up 198% from FY20 Commercial Services business unit delivered...
Global, innovative rapid point-of-care diagnostic company plans expansion and commercialization of suite of...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.